Emerging Trends and Growth Drivers in the Lab Automation In Drug Discovery Market Through 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the Lab Automation In Drug Discovery Market Heading Into 2029?
The market size for lab automation in drug discovery has consistently expanded over the recent years. Starting from a base of $6.47 billion in 2024, the market is anticipated to balloon to $6.77 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.7%. Factors that have contributed to this progressive growth in the historic timespan comprise of increased intricacy in drug discovery, the push for enhanced efficiency and cost-lowering, the pressing requirement for high-throughput screening, growing labor costs, and the demand to quicken the pace of drug development timelines.
Expectations are high for the lab automation in drug discovery sector as it’s projected to experience robust expansion in the forthcoming years. The predicted industry worth will reach “$8.28 billion by 2029, with an annual growth rate of 5.2%. This uplift during the forecast period can be linked to the broadening drug portfolios of pharmaceutical firms, the surge in precision medicine and personalized treatments, intensified focus on rare ailments and orphan drugs, increased demand for remote and decentralized clinical studies, and the advent of microfluidics alongside lab-on-a-chip technologies. The forecast period is also expected to witness the widespread adoption of adaptable and modular automation solutions, the increased use of cloud platforms for managing and sharing data, growth of automation in developing markets, the emergence of virtual drug discovery companies utilizing automation and digital tools, and the creation of standardized protocols and interoperable systems.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp
Which Factors Are Pushing The Lab Automation In Drug Discovery Market Forward?
The surge in the requirement for precision medicine is anticipated to fuel the expansion of lab automation within the drug discovery sector. Precision medicine, or personalized medicine, takes into account the specific genetic, environmental, and lifestyle variations of each individual in medical treatment and prevention strategies. Lab automation expedites research and enhances the regularity of experiments, enhancing the efficacy of precision medicine and drug discovery processes. As a result, it facilitates the generation of more efficient medications and diagnostics tailored to single patients. For example, in October 2022, the Personalized Medicine Coalition (PMC), a US-focused organization advocating the comprehension and utilization of individual medicine, expects the launch of over 75,000 genetic testing products and 300 custom medicines for multiple cancer types, genetic rare diseases, and various chronic and infectious diseases. Thus, the escalating need for precision medicine is stimulating the rise of lab automation in the drug discovery market.
The lab automation in drug discovery market covered in this report is segmented –
1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
2) By Component: Instruments, Software, Services
3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users
Subsegments:
1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations
2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems
3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots
4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems
5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems
Which Emerging Trends And Strategic Shifts Are Shaping The Lab Automation In Drug Discovery Market?
Leading firms in the drug discovery lab automation sector are shifting their attention towards the creation of cutting-edge solutions, like rapid idea-to-data solutions, in order to establish a dominant position in the market. A rapid idea-to-data solution is essentially an efficient process or platform that enables both individuals and corporations to rapidly translate their ideas or concepts into actionable data-driven results or insights. To exemplify, Strateos Inc., an American biotech company, unveiled a rapid idea-to-data solution tailored for small molecule discovery on its cloud lab automation-as-a-service platform in April 2022. This lab automation tool is specifically engineered for small-molecule discovery within drug development. The flexible, on-demand Strateos Cloud Lab Automation-as-a-Service Platform incorporates interconnected robotic automation with 23 workcells and a multitude of instruments. The platform supports streamlined lead generation and optimization, regulated by a software infrastructure that enables users to formulate compounds of interest in the cloud. This allows for automatic assembly and testing utilizing various methods like cell-based, biochemical, and structured-activity relationship (SAR) evaluations.
Which Organizations Are Driving Progress In The Lab Automation In Drug Discovery Industry?
Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation
Which Region Is Expected To Experience The Highest Growth In The Lab Automation In Drug Discovery Industry?
North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
